Multisensory stimulation and PIEZO1 as therapeutic strategies targeting glymphatic and meningeal lymphatic clearance in amyotrophic lateral sclerosis
Active Project Grant Awarded Last action
- Award ID
- HT9425261E149
- Recipient
-
Monash University UEI W2VLWNVNL728
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $839,940
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date 16% complete
- Place of performance
- Australia
Award details come from USAspending.gov.
About this award
The Defense Health Agency awarded Monash University $839,940 on July 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to investigate multisensory stimulation and PIEZO1 as therapeutic strategies targeting glymphatic and meningeal lymphatic clearance in amyotrophic lateral sclerosis. Performance occurs in Australia through June 30, 2028.
Quick answers
Who received award HT9425261E149?
HT9425261E149 was awarded to Monash University by Defense Health Agency (Department of Defense) on July 1, 2026.
How much is award HT9425261E149 worth?
$839,940 has been obligated on HT9425261E149.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award